Clarient Launches New Colorectal Cancer Test 02 July 2008 KRAS test identifies mutation that signals a patient's potential response to specific drug therapies.
Growth Hormone's Link to Starvation May be Clue to Increasing Life Span, UT Southwestern Researchers Find 30 June 2008 Researchers found that starvation blocks the effects of growth hormone via a mechanism that may have implications in treating diabetes and extending life span.
Compugen Announces Discovery of Biomarkers for Early Pre-Clinical Detection of Drug-Induced Kidney Toxicity 30 June 2008 Data demonstrate that the biomarker signature may enable a much earlier prediction of drug-induced kidney toxicity during pre-clinical trials.
Clinical Data Secures EU Patent for MDR1 – A Key Multi-Drug Resistance Gene 30 June 2008 The European Patent Office has granted patent for a gene linked to response to many classes of medications to a wholly-owned subsidiary of Clinical Data.
Rosetta Genomics and Rabin Medical Center Announce Collaboration Focused on MicroRNA-Based Diagnostics 27 June 2008 Collaboration to focus on the development of MicroRNA-based tests for oncology and women's health indications.
GPC Biotech Announces Initiation of NCI-Sponsored Phase 2 Trial of Satraplatin 25 June 2008 Study will evaluate satraplatin in patients with metastatic hormone-refractory prostate cancer previously treated with docetaxel.
UT Southwestern Urologists Identify Seven Biomarkers that may Help Pinpoint Prostate Cancer Recurrence 18 June 2008 A simple blood test may help doctors better predict whether prostate cancer will recur or spread in patients who have undergone surgery for the disease.
FDA, European Medicines Agency to Consider Additional Test Results When Assessing New Drug Safety 13 June 2008 Both agencies will now consider results from the seven new tests as part of their respective drug review processes, which is expected to yield additional safety data.
Orion Genomics Enters Exclusive Worldwide Licensing Agreement with Johns Hopkins University 12 June 2008 Orion Genomics gains exclusive rights to the IGF2 gene for colorectal cancer risk testing.
ONCOMINE™ Again Key to Prostate Cancer Discovery 12 June 2008 Study published in the journal Cancer Cell identifies SPINK1 as a new biomarker for prostate cancer.
Oncolin Therapeutics Signs Agreement with Leading Cancer Center 12 June 2008 Company reaches a sponsored research agreement with M. D. Anderson Cancer Center for the development of a new class of compounds that inhibit glycolysis.
Metabolon Awarded Additional Metabolomics Patent 12 June 2008 The newly issued patent further expands the domain of previously issued patents to include multiple disease states related to nervous systems disorders.
Duke Scientists Show Why Cells Starved of Iron Burn More Sugar 12 June 2008 Scientists have found a metabolic reshuffling mechanism that helps explain how humans respond to iron deficiency, and may help with diabetes research.
Bio-Rad Study Describes Evaluation of Cancer Biomarkers 11 June 2008 Bio-Rad researchers evaluated the Bio-Plex® suspension array system’s ability to detect the levels of nine biomarkers.
Apax Partners Leads Spin-Out of Biomarker Discovery Company Sense Proteomic 09 June 2008 Sense Proteomic spun out of Procognia Ltd by Apax and its management team.